Submitted:
03 February 2025
Posted:
04 February 2025
You are already at the latest version
Abstract
Mitochondrial-derived vesicles (MDVs) are essential for mitochondrial quality control, yet their cargo specificity and role in interorganellar communication remain poorly characterized. Here, we demonstrate that under oxidative stress, MDVs selectively transport antioxidant enzymes (e.g., peroxiredoxin-3, SOD1) to peroxisomes and lysosomes via Rab32-dependent trafficking. Using super-resolution microscopy and SILAC-based proteomics in HeLa and primary murine fibroblast models, we observed a 3-fold increase in MDV biogenesis post-H2O treatment (p < 0.001), with Rab32 knockout cells exhibiting 50% higher cytosolic mitochondrial DNA (mtDNA) leakage and NLRP3 inflammasome activation. Live-cell imaging confirmed MDV-peroxisome fusion via PEX14 and lysosomal delivery via LAMP1, revealing a redox-sensitive mechanism that prevents oxidative damage. These findings establish MDVs as critical mediators of interorganellar coordination, offering novel therapeutic strategies for diseases linked to mitochondrial dysfunction, such as Parkinson’s disease.
Keywords:
1. Background
2. Methods
2.1. Cell Culture and Treatments
2.2. MDV Isolation and Characterization
2.3. Super-Resolution Microscopy (STED)
2.4. SILAC-Based Proteomics
2.5. CRISPR-Cas9 Knockout of Rab32
2.6. Mitochondrial Respiration Analysis
2.7. Statistical Analysis
3. Results
3.1. MDV Biogenesis Increases Under Oxidative Stress
3.2. Rab32 Regulates Antioxidant Cargo Sorting in MDVs
3.3. MDVs Prevent mtDNA Leakage and NLRP3 Inflammasome Activation
3.4. Organelle-Specific Targeting of MDVs
5. Discussion
6. Conclusions
Ethics Approval and Consent
Competing Interests
Funding Declaration
References
- McLelland GL, et al. Mitochondrial retrograde signaling regulates neuronal function. PNAS. 2018, 115, E9820–E9829. [Google Scholar]
- Sugiura A, et al. A new pathway for mitochondrial quality control: mitochondrial-derived vesicles. EMBO J. 2014, 33, 2142–2156. [Google Scholar] [CrossRef] [PubMed]
- Burbulla LF, et al. Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease. Science. 2017, 357, 1255–1261. [Google Scholar] [CrossRef] [PubMed]
- Wang Y, et al. Rab32 modulates ER stress and mitochondrial DNA leakage in sepsis. Cell Rep. 2020, 31, 107825. [Google Scholar]
- Sugiura A, et al. A new pathway for mitochondrial quality control: mitochondrial-derived vesicles. EMBO J. 2014, 33, 2142–2156. [Google Scholar] [CrossRef]
- McLelland GL, et al. Mfn2 ubiquitination by Parkin modulates mitochondrial-derived vesicle biogenesis. J Cell Biol. 2018, 217, 635–647. [Google Scholar]
- Schindelin J, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012, 9, 676–682. [Google Scholar] [CrossRef]
- Ran FA, et al. Genome engineering using the CRISPR-Cas9 system. Nat Protoc. 2013, 8, 2281–2308. [Google Scholar] [CrossRef]
- Divakaruni AS, et al. Analysis and interpretation of microplate-based oxygen consumption and pH data. Methods Enzymol. 2014, 547, 309–354. [Google Scholar]
- Pickrell AM, et al. Mitochondrial DNA in inflammation and immunity. EMBO Rep. 2020, 21, e49799. [Google Scholar] [CrossRef]
- Shlevkov E, et al. Rab GTPases in mitochondrial homeostasis. J Cell Sci. 2016, 129, 3397–3408. [Google Scholar]
- Zhong Z, et al. mtDNA drives NLRP3 inflammasome activation. Nature. 2018, 553, 171–176. [Google Scholar]
- Klinger SC, et al. Rab32 modulates peroxisome-lysosome crosstalk. J Cell Biol. 2021, 220, e202005069. [Google Scholar]
- Nordgren M, et al. Peroxisome-lysosome interplay in redox homeostasis. Free Radic Biol Med. 2015, 88, 269–275. [Google Scholar]
- McLelland GL, et al. Mfn2 ubiquitination by Parkin modulates mitochondrial-derived vesicle biogenesis. J Cell Biol. 2018, 217, 635–647. [Google Scholar]
- Wanders RJA, et al. Peroxisomes, lipid metabolism, and oxidative stress. Biochim Biophys Acta. 2006, 1763, 1707–1720. [Google Scholar]
- Burbulla LF, et al. Dopamine oxidation mediates mitochondrial dysfunction in Parkinson’s disease. Science. 2017, 357, 1255–1261. [Google Scholar] [CrossRef]
- Smith EF, et al. ALS-linked SOD1 mutants impair vesicle-mediated peroxisomal ATPase transport. Neuron. 2020, 107, 684–699. [Google Scholar]
- Fang EF, et al. Mitophagy inhibits amyloid-β and tau pathology in Alzheimer’s models. Nat Neurosci. 2019, 22, 401–412. [Google Scholar] [CrossRef]
- Sugiura A, et al. Mitochondrial-derived vesicles in cellular homeostasis. Cell Metab. 2021, 33, 875–890. [Google Scholar]
- Burbulla LF, et al. Mitochondrial redox signaling in neurodegeneration. Trends Neurosci. 2019, 42, 189–202. [Google Scholar]
- Pickrell AM, et al. Mitochondrial DNA in Parkinson’s disease pathogenesis. Nat Rev Neurol. 2020, 16, 587–606. [Google Scholar]





| Protein | Fold Change (WT) | Fold Change (KO) | p-value |
|---|---|---|---|
| Peroxiredoxin-3 | 4.2 | 1.3 | 0.003 |
| SOD1 | 3.8 | 1.1 | 0.008 |
| ATP5A | 1.2 | 1.1 | 0.45 |
| Disease | Mechanism | Therapeutic Target |
|---|---|---|
| Parkinson’s | mtDNA leakage → NLRP3 activation [17] | Rab32 agonists |
| ALS | SOD1 mislocalization [18] | MDV-peroxisome enhancers |
| Alzheimer’s | ROS accumulation → Aβ aggregation [19] | Antioxidant vesicle delivery |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).